You have 9 free searches left this month | for more free features.

colony stimulating factor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)

Recruiting
  • Primary Ovarian Insufficiency
  • Premature Ovarian Failure
  • Toronto, Ontario, Canada
    Trio Fertility
Oct 31, 2023

Alcoholic Hepatitis Trial in Chandigarh (Standard Medical Therapy, G-CSF, G-CSF and NAC)

Completed
  • Alcoholic Hepatitis
  • Standard Medical Therapy
  • +2 more
  • Chandigarh, India
    Dept of Hepatology, PGIMER
Apr 29, 2023

Neuroblastoma Trial (Naxitamab)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Sep 18, 2023

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Intrauterine Infusion of GCSF and Reproductive Outcomes in

Recruiting
  • Recurrent Implantation Failure
  • +2 more
  • Granulocyte Colony-Stimulating Factor
  • placebo
  • Cairo, AlQuahira, Egypt
    Cairo university Kasr Alainy OBGYN hospital
Jun 8, 2022

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

Not yet recruiting
  • Secondary Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 22, 2023

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))

Recruiting
  • Pediatric Cancer
  • +4 more
  • G-CSF administration (bolus injection versus intravenous infusion)
  • Taoyuan, ROC, Taiwan
    Chang Gung Children Hospital
Nov 21, 2023

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

Not yet recruiting
  • Granulocyte Colony-Stimulating Factor
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8 With GM-CSF
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 2, 2022

Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,

Recruiting
  • Breast Ductal Carcinoma In Situ
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +2 more
  • Jacksonville, Florida
  • +1 more
Dec 10, 2021

Granulocyte Colony Stimulating Factor Versus Platelet Rich

Completed
  • Infertility
  • Granulocyte Colony Stimulating Factor
  • +2 more
  • Maadi, Cairo, Egypt
    Wael El-Banna Clinic
Nov 27, 2021

Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Jun 8, 2023

Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

Completed
  • Breast Cancer
  • Autologous, Lethally Irradiated Breast Cancer Cells
  • Boston, Massachusetts
  • +1 more
Mar 30, 2022

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast

Withdrawn
  • Anterior Myocardial Infarction
  • Heart Failure
  • rhu G-CSF
  • +2 more
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli
Mar 28, 2022

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Improved Methods of Cell Selection for Bone Marrow Transplant

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022